Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | EDP1503 |
Trade Name | |
Synonyms | EDP 1503|EDP-1503 |
Drug Descriptions |
EDP1503 is an oral dose of monoclonal Bifidobacterium, which may induce an antitumor immune response and inhibition of tumor growth (Cancer Res 2021;81(4 Suppl):Abstract nr PS11-27). |
DrugClasses | Microbiome 7 |
CAS Registry Number | NA |
NCIT ID | C155907 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
EDP1503 | EDP1503 | 0 | 1 |
EDP1503 + Pembrolizumab | EDP1503 Pembrolizumab | 0 | 2 |